What is the myc biomarker? Does this relate to double hit
According to the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas:
- MYC is a gene that helps control cell growth and division
- When the MYC gene becomes rearranged (moved from its normal position), it can lead to more aggressive lymphoma behavior
- MYC rearrangements are typically detected through FISH (fluorescence in situ hybridization) testing
The Leukemia & Lymphoma Society (LLS) explains that "double-hit lymphoma" refers to:
- Lymphomas that have TWO genetic rearrangements:
- MYC rearrangement AND
- Either BCL2 or BCL6 rearrangement
- This combination is now officially classified as "High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements"
- These lymphomas typically behave more aggressively and require specific treatment approaches
According to ASCO (American Society of Clinical Oncology) guidelines:
- Double-hit lymphomas generally require more intensive chemotherapy regimens than standard DLBCL
- The presence of MYC rearrangement alone or with other mutations helps doctors determine: • Prognosis • Treatment selection • Clinical trial eligibility
Always consult with your healthcare team about your specific genetic test results and what they mean for your treatment plan, as interpretation can be complex.
Your next question, already answered
Tap to keep going. 2 free answers, then a free account.
Ask Navis about your case
That answer is general. Ask about your specific situation. Answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Sources & medical oversight
- Grounded in NCCN Guidelines for Patients (Lymphomas) — the same guidelines oncologists use.
- Built by OpenCancer’s team of physician-scientists and cancer survivors.
- Last updated October 15, 2025. Informational only — not a substitute for your oncology team.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Source Guidelines
NCCN Guidelines for Patients (Lymphomas) (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with diagnosis for Lymphoma patients
Have your records handy? Add them to a private case for a deeper, personalized read →
Expert Webinars on Lymphoma
More questions about Lymphoma
- What biomarker testing is recommended for early stage Lymphoma
- In more detail what each of these biomarker tests are measuring and how they inform treatment decisions for my type...
- Recurred. How does this change my treatment choices, and are new targeted therapies using biomarkers (CD20, PD-L1)...
- Hi fellow lymphoma patients. I'm on r-chop with 5 out of 6 infusions. My lungs started hurting a few weeks ago and...
- Has anyone done BITE immunotherapy? If so what was it like? The chemo is done and lymphoma is already back five...
- Differences between Non Hodgkin Lymphoma and classic Hodgkin's Lymphoma
- I’ve had 5 treatments so far. I feel so hungry and just can’t eat. I’ve craved fried chicken throughout this and...
- Can anyone explain to me what are the benefits and risks of CAR-T. I relapsed two months after finishing my chemo...